News & Analysis

Latest content

Amgen’s Federal Circuit victory vindicates $13.4 billion Otezla IP acquisition

The company took a calculated risk by paying billions for drug while a slew of patent challenges were ongoing

25 April 2023

US patent litigation against top automakers rose 32% in 2022

Docket Navigator data shows a 2022 uptick in district court and PTAB cases involving 12 of the world's biggest vehicle OEMs, but there's indication of lower numbers this year

24 April 2023

Active case management and the role of boutique patent firms in pan-European disputes

With the UPC launch just weeks away, in-house counsel should consider how to best employ representation for multi-jurisdictional conflict

24 April 2023

Ocado offensive; Samsung signs to Avanci; ROI annual report; Pure Storage on inclusive innovation; PTAB reform proposal; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days

23 April 2023

The European Commission’s SEP regulation would be a geostrategic liability for the EU

Saturday Opinion: As ESTI and key US players move to intervene, the geopolitical ramifications of the proposal start to show

22 April 2023

Patent owners will welcome parts of USPTO’s PTAB reform proposal

Director Kathi Vidal’s proposed rules would expand discretionary denial into new categories, but heightened disclosure requirements might pain patentees and petitioners alike

21 April 2023

From gatekeeper to gateway: Pure Storage patent team continues to redefine inclusive innovation

A new programme is encouraging untapped potential innovators to speak up - with positive results

21 April 2023

The EPO’s latest plausibility decision is good news for applicants and patentees

The Enlarged Board of Appeal's ruling in G2/21 has significant implications for the use of post-filed data

21 April 2023

Finding stealth prior art before it finds you

Lessons should be learned from Minerva’s mistakes to avoid costly patent protection errors

20 April 2023

Patent cliff concerns drive Merck’s $11 billion Prometheus buyout

Deal hoped to stave off investor concerns about expiring patents and diversify product pipeline

20 April 2023

Unlock unlimited access to all IAM content